Immunohistochemistry (IHC), immunofluorescence (IF), and histological stains provide valuable insights into the distribution of relevant biomarkers and structural changes in tissue samples. At Visikol, we understand the importance of accurate and efficient analysis in evaluating biomarkers for disease pathology. That’s why we offer a comprehensive suite of services for the quantification and analysis of IHC sections.
Traditionally, the analysis of IHC slides involved subjective interpretation by a pathologist, often relying on scoring systems to assess the presence or absence of specific markers. However, with the advancement of computational techniques and image processing, we can now achieve quantitative analysis on a large scale and in a fraction of the time.
Our Biomarker Area Quantification service utilizes cutting-edge technology to provide robust and reliable quantification of biomarkers in tissue sections. We employ a sophisticated thresholding approach to segment the biomarkers of interest, followed by accurate measurement of their respective areas. This enables us to precisely quantify the extent and distribution of specific biomarkers within the tissue samples.
Moreover, we understand that the interaction between multiple biomarkers can be crucial in understanding disease mechanisms. Our service also includes the evaluation of biomarker colocalization, allowing us to assess the degree of coincidence between different markers. This analysis provides valuable insights into the examination of changes in biomarker expression within tissues.
By leveraging our state-of-the-art image analysis software and expertise in bio-image analysis, we ensure the highest level of accuracy and reproducibility in our quantification services. Our team of experienced scientists is dedicated to delivering precise results and helping you gain deeper insights into your research.